Scientific Publication

Dual silencing of integrin αvβ3 receptor and insulin-like growth factor 1 receptor using mPEG-PCL/DDAB hybrid nanoparticle loaded siRNA in breast cancer therapy: An in vitro study on MCF-7 cells

Journal: International Journal of Biological Macromolecules
Year: 2024
Impact Factor: 8.5
DOI: 10.1016/j.ijbiomac.2024.139334

Abstract

Mennati A, Rostamizadeh K, Fathi M (2024). Novel hybrid nanocarrier co-silencing integrin αvβ3 and IGF-1R for targeted MCF-7 breast cancer therapy.

Detailed Discussion & Nanotech Implementation

Mennati A, Rostamizadeh K, Fathi M (2024). Novel hybrid nanocarrier co-silencing integrin αvβ3 and IGF-1R for targeted MCF-7 breast cancer therapy.

Authors: Mennati A, Rostamizadeh K, Fathi M
Journal: International Journal of Biological Macromolecules (2024)
DOI/Ref: 10.1016/j.ijbiomac.2024.139334
URL: https://doi.org/10.1016/j.ijbiomac.2024.139334

انتشارات مرتبط